Quick Answer
Tectonic Therapeutic, Inc. reported Earnings Per Share Diluted of $4.05 (loss) per share for the year ending 2025.
- Tectonic Therapeutic, Inc. showed an increase of +40.7% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Tectonic Therapeutic, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $0.74 (loss) per share | Q3 2021: $0.75 (loss) per share | Q1 2022: $0.68 (loss) per share | Q2 2022: $0.64 (loss) per share | Q3 2022: $0.52 (loss) per share | Q1 2023: $0.57 (loss) per share | Q2 2023: $8.51 (loss) per share | Q3 2023: $7.62 (loss) per share | Q1 2024: $10.97 (loss) per share | Q2 2024: $4.34 (loss) per share | Q3 2024: $1.20 (loss) per share | Q1 2025: $0.93 (loss) per share | Q2 2025: $1.07 (loss) per share | Q3 2025: $1.02 (loss) per share.
- Over the full 5 years of available data (2021 to 2025), Tectonic Therapeutic, Inc.'s Earnings Per Share Diluted has declined by 45.7%.
- Historical annual values: Fiscal year 2025: $4.05 (loss) per share | Fiscal year 2024: $6.83 (loss) per share | Fiscal year 2023: $33.76 (loss) per share | Fiscal year 2022: $2.42 (loss) per share | Fiscal year 2021: $2.78 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: